Current Role of Lipoprotein Apheresis

Area of Science:

• Cardiovascular Medicine
• Lipidology

Background:

• Lipoprotein apheresis is an established therapy for managing severe dyslipidemias.
• It effectively reduces low-density lipoprotein cholesterol, lipoprotein(a), and other atherogenic lipoproteins.
• Historically considered a last resort, its role is re-evaluated with new lipid-lowering drugs.

Purpose of the Study:

• To define the current role of lipoprotein apheresis in managing dyslipidemias.
• To assess its place alongside novel potent lipid-lowering therapies.
• To review its application in specific patient groups, including those with high lipoprotein(a).

Main Methods:

• Review of existing literature and clinical guidelines.
• Analysis of lipoprotein apheresis efficacy in various dyslipidemic conditions.
• Comparison with current pharmacological lipid-lowering strategies.

Main Results:

• Lipoprotein apheresis remains vital for homozygous familial hypercholesterolemia and drug-resistant hypercholesterolemia.
• It is effective for patients intolerant or unresponsive to modern lipid-lowering drugs.
• Its use in reducing lipoprotein(a) in patients with cardiovascular disease is highlighted, despite varied recommendations.

Conclusions:

• Lipoprotein apheresis is an important tool for severe, drug-resistant dyslipidemias, particularly homozygous familial hypercholesterolemia.
• It addresses unmet needs in patients with inadequate response or intolerance to current therapies.
• Its role in managing elevated lipoprotein(a) warrants consideration in specific clinical scenarios.